Results 31 to 40 of about 230,496 (168)

Clinical effectiveness of hymenoptera venom immunotherapy [PDF]

, 2013
Treatment failure during venom immunotherapy (VIT) may be associated with a variety of risk factors. Our aim was to evaluate the association of baseline serum tryptase concentration (BTC) and of other parameters with the frequency of VIT failure during ...
Scheipl, Fabian, Darsow, Ulf, Reider, Norbert, Bonifazi, Floriano, Aberer, Werner, Schmid-Grendelmeier, Peter, Ruëff, Franziska, Treudler, Regina, Biló, Maria Beatrice, Sturm, Gunter Johannes, Küchenhoff, Helmut, Severino, Maurizio, Wüthrich, Brunello, Seitz, Michael J., Quercia, Oliviero, Bodzenta-Lukaszyk, Anna, Lang, Roland, Haeberli, Gabrielle, Campi, Paolo, Hawranek, Thomas, Müller, Ulrich, Przybilla, Bernhard   +21 more
core   +1 more source

Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications

, 2023
In recent years, cancer immunotherapy research has made remarkable progress, completely transforming the cancer treatment landscape [...
Timothy Starr, Subbaya Subramanian, Xianda Zhao   +2 more
core   +1 more source

Immunotherapy

Journal of the Royal College of Physicians of London, 1999
A forward looking conference took place at the Royal College of Physicians in June 1998. The audience, which included many scientific and clinical immunologists from both the university and pharmaceutical sector, participated knowledgeably and critically in the discussions on possible future treatments for immunologically caused diseases and on the ...
openaire   +2 more sources

Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor Progression

, 2021
Human colorectal cancers are mostly microsatellite-stable with no response to anti-PD-1 blockade immunotherapy, necessitating the development of a new immunotherapy.
John D. Klement, Alyssa D. Merting, Chunwan Lu, Kebin Liu, Dakota B. Poschel, Dafeng Yang, Priscilla S. Redd   +6 more
core   +1 more source

Vaccination-induced skin-resident memory CD8+ T cells mediate strong protection against cutaneous melanoma

OncoImmunology, 2018
Memory CD8+ T cell responses have the potential to mediate long-lasting protection against cancers. Resident memory CD8+ T (Trm) cells stably reside in non-lymphoid tissues and mediate superior innate and adaptive immunity against pathogens.
Felipe Gálvez-Cancino, Ernesto López, Evelyn Menares, Ximena Díaz, Camila Flores, Pablo Cáceres, Sofía Hidalgo, Ornella Chovar, Marcela Alcántara-Hernández, Vincenzo Borgna, Manuel Varas-Godoy, Flavio Salazar-Onfray, Juliana Idoyaga, Alvaro Lladser   +13 more
doaj   +1 more source

Immunotherapy

International Journal of Clinical Practice, 1989
A new era of immunotherapy is arriving in medical therapeutics. Both immunosupresion and immunomodulation have advantages which the clinician must learn. In this review, the author describe several immunomodulators which include cytokines, interleukins, interferons, tumor necrosis factor, granulocyte colony-stimulating factor, erythropoietin, and ...
openaire   +4 more sources

Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical Tumors [PDF]

, 2023
Endometrial cancer (EC) is the seventh most common tumor in women, and prognosis of recurrent and metastatic disease is poor. Cervical cancer (CC) represents the fifth most common gynecological cancer.
Hasan, Uzma, Lainé, Alexandra, Isabelle Ray-Coquard, Ray-Coquard, Isabelle, Ryotaro Ohkuma, Uzma Hasan, Gonzalez-Lopez, Andrea M, Ohkuma, Ryotaro, Andrea M. Gonzalez-Lopez, Alexandra Lainé, Gonzalez-Lopez, Andrea M.   +10 more
core   +1 more source

The Current and Future Promises of Combination Radiation and Immunotherapy for Genitourinary Cancers

, 2022
As the indications for the use of immunotherapy in genitourinary malignancies expand, its role in combination with standard or conventional therapies has become the subject of contemporary studies.
Isabella Dolendo, Rana R. McKay, Aditya Bagrodia, Ava Saidian, Amirali Salmasi, Brent Rose, Andrew Sharabi, Tyler F. Stewart   +7 more
core   +1 more source

A Bead-Based Screening Platform for Identifying Monoclonal Antibodies That Disrupt PD-1/PD-L1 Interactions

Journal of Immunology Research
Monoclonal antibodies (mAbs) targeting immune checkpoint pathways such as programmed cell death protein 1 (PD-1)/PD-L1 are central to modern immunotherapy, yet scalable methods to assess their functional blockade remain limited.
Veridiane M. Pscheidt, Rodrigo B. Gassen, José E. Sacconi Nunes, Deise do Nascimento de Freitas, Valdir Barth, Fernanda B. Frozza, Milena D. Santos, Claudia P. Nunes, Cristina B. C. Bonorino   +8 more
doaj   +1 more source

Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem

Nanoscale Research Letters, 2020
Liver cancer is one of the most common malignancies worldwide. The RAF kinase inhibitors are effective in the treatment of hepatocellular carcinoma (HCC); therefore, inhibition of the BRAF/MEK/ERK pathway has become a new therapeutic strategy for novel ...
Yanling Liu, Manman Tan, Yujuan Zhang, Wei Huang, Liangliang Min, Shanshan Peng, Keng Yuan, Li Qiu, Weiping Min   +8 more
doaj   +1 more source